dc.contributor.author | Santos Beneit, Fernando | |
dc.date.accessioned | 2025-06-20T09:05:32Z | |
dc.date.available | 2025-06-20T09:05:32Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | MicrobiologyOpen, 2024, Vol. 13, Núm. 2, e1406 | es |
dc.identifier.issn | 2045-8827 | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/76058 | |
dc.description | Producción Científica | es |
dc.description.abstract | Microbial products are essential for developing various therapeutic agents, including
antibiotics, anticancer drugs, vaccines, and therapeutic enzymes. Genetic engineering
techniques, functional genomics, and synthetic biology unlock previously
uncharacterized natural products. This review highlights major advances in microbial
biotechnology, focusing on gene‐based technologies for medical applications. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | John Wiley & Sons Ltd. | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Antibiotics | es |
dc.subject | Biotechnology | es |
dc.subject | Genetic engineering | es |
dc.subject | Medicine | es |
dc.subject | Microbiology | es |
dc.title | What is the role of microbial biotechnology and genetic engineering in medicine? | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | 10.1002/mbo3.1406 | es |
dc.identifier.publicationissue | 2 | es |
dc.identifier.publicationtitle | MicrobiologyOpen | es |
dc.identifier.publicationvolume | 13 | es |
dc.peerreviewed | SI | es |
dc.identifier.essn | 2045-8827 | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |